CLINICAL_TRIALS
trial_result
· 2025-09-26
Clinical Trial Update: Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome [Phase 2]
Summary
The Phase 2 pharmacokinetics study of DESF in adults with oral allergy syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aquestive Therapeutics | Conditions: Allergic Reaction | Phase 2 | Status: COMPLETED